The COVID-19 pandemic has had a tremendous impact on every aspect of our life and society, and everywhere in the world we needed to face unprecedented situations. At the same time, COVID-19 provided an opportunity to reconsider the relationship between humans/society and S&T, as well as a motivation to question existing framework of co-creation with society with regard to infection research. AMED and RISTEX (JST) called for proposals in FY2020 for surveys and R&D that focused on ethical, legal, and social implications/issues (ELSI) of emerging infectious diseases. This session will be held to provide a space for researchers to report on the results of surveys and the progress of projects, and to stimulate discussion based on diverse viewpoints of "ELSI of emerging infectious diseases" provided by researchers at the frontline of COVID-19 research.


Time & Date : 05:30 - 08:30 (UTC) November 23, 2021

Venue : Online Webinar (Live stream)

Language : Japanese

Co-organizer : Japan Agency for Medical Research and Development (AMED), Research Institute of Science and Technology for Society (RISTEX) Japan Science and Technology Agency (JST)

Open to Public : Fee free *Please register the following application form

Application Form


05:30 - 05:35 Opening Remarks

IWATA Satoshi

05:35 - 06:55 Session 1: from the Perspective of Risk Communication

  • (RISTEX)
    Speech: KODAMA Satoshi
    Comment: SHINOMIYA Nariyoshi
  • (AMED)
    Speech: NISHII Shozo
    Comment: KAWAKAMI Masahiro
  • (AMED)
    Speech: MIURA Asako
    Comment: MINARI Jyusaku
  • (RISTEX)
    Speech: TANAKA Mikihito
    Comment: KARASAWA Kaori
  • Discussion

06:55 - 07:05 Break

07:05 - 08:25 Session 2: from the Perspective of ELSI in Infectious Diseases

  • (RISTEX)
    Speech: HAYASHI Yoshitsugu
    Comment: HARAYAMA Yuko
  • (RISTEX)
    Speech: YONEMURA Shigeto
    Comment: OHYA Takehiro
  • (AMED)
    Speech: NAKADA Haruka
    Comment: MINARI Jyusaku
  • (AMED)
    Speech: YOSHIDA Masayuki
    Comment: IWATA Satoshi
  • Discussion

08:25 - 08:30 Closing Remarks



Division of Genomic Medicine,Department of Health and Clinical Data, Japan Agency for Medical Research and Development
✉️ genome-elsi [at]

Research Institute of Science and Technology for Society, Japan Science and Technology Agency
✉️ ristex-elsi [at]


AMED | Infectious Diseases R&D ELSI Program
JST-RISTEX | R&D Program: Responsible Innovation with Conscience and Agility EventsAll Topics
Go to Top